View Item 

Show simple item record

Inhibition of neutrophil activation by p ‐bromophenacyl bromide and its effects on phospholipase A 2

dc.contributor.authorDuque, Ricardo E.en_US
dc.contributor.authorFantone, Joseph C.en_US
dc.contributor.authorKramer, Craigen_US
dc.contributor.authorMarasco, Wayne A.en_US
dc.contributor.authorPhan, Sem H.en_US
dc.date.accessioned2012-08-09T14:54:25Z
dc.date.available2012-08-09T14:54:25Z
dc.date.issued1986-06en_US
dc.identifier.citationDuque, Ricardo E.; Fantone, Joseph C.; Kramer, Craig; Marasco, Wayne A.; Phan, Sem H. (1986). "Inhibition of neutrophil activation by p ‐bromophenacyl bromide and its effects on phospholipase A 2 ." British Journal of Pharmacology 88(2). <http://hdl.handle.net/2027.42/92354>en_US
dc.identifier.issn0007-1188en_US
dc.identifier.issn1476-5381en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/92354
dc.publisherWiley Periodicals, Inc.en_US
dc.publisherBlackwell Publishing Ltden_US
dc.titleInhibition of neutrophil activation by p ‐bromophenacyl bromide and its effects on phospholipase A 2en_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, U.S.A.en_US
dc.identifier.pmid3015312en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/92354/1/j.1476-5381.1986.tb10225.x.pdf
dc.identifier.doi10.1111/j.1476-5381.1986.tb10225.xen_US
dc.identifier.sourceBritish Journal of Pharmacologyen_US
dc.identifier.citedreferenceSchiffmann, E., Aswanikumar, S., Venkatasubraminian, K., Corcoran, B.A., Pert, C.B., Brown, J., Gross, E., Day, A.R., Freer, R.J., Showell, H.J. & Becker, E.L. ( 1980 ). Some characteristics of the neutrophil receptor for chemotactic peptides. FEBS Lett., 117, 1 – 7.en_US
dc.identifier.citedreferenceLanni, C. & Becker, E.L. ( 1983 ). Release of phospholipase A2 activity from rabbit peritoneal neutropils by f Met‐Leu‐Phe. Am. J. Pathol., 113, 90 – 94.en_US
dc.identifier.citedreferenceLanni, C. & Becker, E.L. ( 1985 ). Inhibition of neutrophil phospholipase A2 by p‐bromophenacyl bromide, nordihydroguiaretic acid, 5, 18, 11, 14‐eicosatetraynoic acid and quercetin. Int. Archs Allergy appl. Immunol., 76, 214 – 221.en_US
dc.identifier.citedreferenceLaris, P.C., Pershadsingh, H.A. & Johnstone, R.M. ( 1976 ). Monitoring membrane potentials in Ehrlich ascites tumor cells by means of a fluorescent dye. Biochim. biophys. Acta., 436, 475 – 488.en_US
dc.identifier.citedreferenceMarasco, W.A., Fantone, J.C., Freer, R.J. & Ward, P.A. ( 1983 ). Characterization of the rat neutrophil formyl peptide receptor. Am. J. Pathol., 111, 273 – 281.en_US
dc.identifier.citedreferenceMcCord, J.N. & Fridovich, I. ( 1969 ). Superoxide dismutase, an enzymatic function for erythrocupreine (Leuocupreine). J. biol. Chem., 244, 6049 – 6055.en_US
dc.identifier.citedreferenceMcPhail, L.C., Dechatelet, L.R. & Shirley, P.S. ( 1976 ). Further characterization of NADPH oxidase activity of human polymorphonuclear leukocytes. J. clin. Invest., 58, 774 – 780.en_US
dc.identifier.citedreferenceNiedel, J. ( 1981 ). Detergent solubilization of the formyl peptide chemotactic receptor. Strategy based on covalent affinity labeling. J. biol. Chem., 256, 9295 – 9299.en_US
dc.identifier.citedreferenceRoberts, M.F., Deems, R.A., Mincey, T.C. & Dennis, E.A. ( 1977 ). Chemical modification of the histidine residue in phospholipase A2 ( Naja naja naja ). J. biol. Chem., 252, 2405 – 2411.en_US
dc.identifier.citedreferenceSklar, L.A., Jesaitas, A.J., Painter, R.G. & Cochrane, C.G. ( 1980 ). The kinetics of neutrophil activation. J. biol. Chem., 256, 9909 – 9914.en_US
dc.identifier.citedreferenceSmith, T.C., Herlihy, J.T. & Robinson, S.C. ( 1981 ). The effect of the fluorescent probe, 3,3′‐dipropylthia‐dicarbocyanine iodide, on the energy metabolism of ehrlich ascites tumor cells. J. biol. Chem., 256, 1108 – 1110.en_US
dc.identifier.citedreferenceSmolen, J.E. & Weissmann, G. ( 1980 ). Effects of indomethacin, 5,8,11,14‐eicosatetraynoic acid, and p‐bromophenacylbromide on lysosomal enzyme release and superoxide anion generation by human polymorphonuclear leukocytes. Biochem. Pharmac., 29, 533 – 538.en_US
dc.identifier.citedreferenceStanley, P.E. & Williams, S.G. ( 1969 ). Use of the liquid scintillation spectrometer for determining adenosine triphosphate by the luciferase enzyme. Analyt. Biochem., 29, 381 – 392.en_US
dc.identifier.citedreferenceVictor, M., Weiss, J., Klempner, M.S. & Elsbach, P. ( 1981 ). Phospholipase A2 activity in the plasma membrane of human polymorphonuclear leukocytes. FEBS Lett., 136, 298 – 300.en_US
dc.identifier.citedreferenceWalsh, C.E., De Chatelet, R., Thomas, M.J., O'Flaherty, J.T. & Waite, M. ( 1980 ). Effect of phagocytosis and ionophores on release and metabolism of arachidonic acid from human neutrophils. Lipids, 16, 120 – 124.en_US
dc.identifier.citedreferenceWalsh, C.E., Waite, M., Thomas, M.J. & Dechatelet, L.R. ( 1981 ). Release and metabolism of arachidonic acid in human neutrophils. J. biol. Chem., 256, 7228 – 7234.en_US
dc.identifier.citedreferenceWeissman, G., Smolen, J.E. & Korchak, H.N. ( 1980 ). Release of inflammatory mediators from stimulated neutrophils. N. Engl. J. Med., 303, 27 – 34.en_US
dc.identifier.citedreferenceWhitin, J.C., Chapman, C.E., Simons, E.R., Chovaniec, M.E. & Cohen, H.J. ( 1980 ). Correlation between membrane potential changes and superoxide anion production in human granulocytes stimulated by phorbol myristate acetate. Evidence for defective activation in chronic granulomatous disease. J. biol. Chem., 255, 1874 – 1878.en_US
dc.identifier.citedreferenceYorio, T., Torres, S. & Tarapoom, N. ( 1983 ). Alteration in membrane permeability by diacylglycerol and phosphatidylcholine containing arachidonic acid. Lipids, 18, 96 – 99.en_US
dc.identifier.citedreferenceAckerman, S.K., Matter, L. & Douglas, S.D. ( 1983 ). Effects of acid proteinase inhibitors on human neutrophil chemotaxis and lysosomal enzyzme release. Clin. Immunol. Immunopath., 26, 213 – 222.en_US
dc.identifier.citedreferenceBecker, E.L. ( 1972 ). The relationship of the chemotactic behavior of the complement‐derived factors, C3a, C5a, and C567, and a bacterial chemotactic factor to their ability to activate the proesterase 1 of rabbit polymorphonuclear leukocytes. J. exp. Med., 135, 376 – 378.en_US
dc.identifier.citedreferenceBecker, E.L., Henson, P.M., Showell, H.J. & Hsu, L.S. ( 1977 ). The ability of chemotactic factors to induce lysosomal enzyme release I. The characteristics of the release, the importance of surfaces and the relation of enzyme release to chemotactic responsiveness. J. Immunol., 112, 2047 – 2054.en_US
dc.identifier.citedreferenceBell, R.L., Kennerly, D.A., Stanford, N. & Majerus, P.W. ( 1979 ). Diglyceride lipase: A pathway for arachidonate release from human platelets. Proc. natn. Acad. Sci, U.S.A., 76, 3238 – 3241.en_US
dc.identifier.citedreferenceBerridge, M.J. ( 1984 ). Inositol triphosphate and diacylglycerol as second messengers. Biochem. J., 220, 345 – 360.en_US
dc.identifier.citedreferenceBligh, E.G. & Dyer, W.J. ( 1959 ). A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol., 37, 911 – 917.en_US
dc.identifier.citedreferenceBormann, B.J., Huang, C‐K., Kackin, W.M. & Becker, E.L. ( 1984 ). Receptor mediated activation of a phospholipase A2 in rabbit neutrophil plasma membrane. Proc. natn. Acad. Sci. U.S.A., 81, 767 – 772.en_US
dc.identifier.citedreferenceDeakin, H., Ord, M.G. & Stocken, L.A. ( 1963 ). Glucose 6‐phosphate‐dehydrogenase' activity and thiol content of thymus nuclei from control and x‐irradiated rats. Biochem. J., 89, 296 – 304.en_US
dc.identifier.citedreferenceDerksen, A. & Cohen, P. ( 1975 ). Patterns of fatty acid release from endogenous substrates by human platelet homogenates and membranes. J. biol. Chem., 150, 9347 – 9357.en_US
dc.identifier.citedreferenceDuque, R.E., Phan, S.H., Sulavik, M.C. & Ward, P.A. ( 1983 ). Inhibition by tosyl‐L‐phenylalanine chloromethyl ketone of membrane potential changes in rat neutrophils. Correlation with the inhibition of biological activity. J. biol. Chem., 258, 8123 – 8128.en_US
dc.identifier.citedreferenceFranson, R., Beckerdite, S., Wang, P., Waite, M. & Elsbach, P. ( 1973 ). Some proper ties of phospholipases of alveolar macrophages. Biochim. biophys. Acta, 296, 365 – 371.en_US
dc.identifier.citedreferenceFranson, R., Patrarca, P. & Elsbach, P. ( 1974 ). Isolation and characterization of a phospholipase A2 from an inflammatory exudate. J. Lipid Res., 15, 380 – 388.en_US
dc.identifier.citedreferenceGoetzl, E.J. ( 1980 ). Mediators of immediate hypersensitivity derived from arachidonic acid. N. Engl. J. Med., 303, 822 – 825.en_US
dc.identifier.citedreferenceGross, E. & Morell, J.L. ( 1966 ). Evidence for an active carboxyl group in pepsin. J. biol. Chem., 241, 3638 – 3642.en_US
dc.identifier.citedreferenceHofmann, S.L., Prescott, S.M. & Majerus, P.W. ( 1982 ). The effects of mepacrine and p‐bromophenacyl bromide on arachidonic acid release in human platelets. Archs Biochem. Biophys., 215, 237 – 244.en_US
dc.identifier.citedreferenceKeuhl, F.A. Jr. & Egar, R.W. ( 1980 ). Prostaglandins, arachidonic acid, and inflammation. Science, 210, 978 – 984.en_US
dc.identifier.citedreferenceKyger, E.M. & Franson, R.C. ( 1984 ). Nonspecific inhibition of enzymes by p‐bromophenacyl bromide: Inhibition of human platelet phospholipase C and modification of sulfhydryl groups. Biochim. biophys. Acta, 794, 96 – 103.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1476-5381.1986.tb10225.x.pdf
Size:
1.391MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.